Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 24 February 2009
Vol. 2, Issue 59, p. re1
[DOI: 10.1126/scisignal.259re1]

REVIEWS

Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands

Yihai Cao*

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.

Abstract: Vascular endothelial growth factor–A (VEGF-A) is a key target for new antiangiogenic drugs for the treatment of both malignant and nonmalignant human diseases. Vascular effects of VEGF family members are mainly mediated by VEGF receptor 2 (VEGFR2). Conversely, the function and signaling of VEGFR1, which is present on endothelial and nonendothelial cells, are poorly understood. Intriguingly, two of five members in the VEGF family—VEGF-B and placental growth factor (PlGF)—are exclusive ligands for VEGFR1 and do not interact with the other VEGFRs, VEGFR2 and VEGFR3. These VEGFR1-specific ligands may be important therapeutic targets for the treatment of cancer. This review discusses the distinctive roles of VEGFR1 and its ligands PlGF and VEGF-B in the mediation of angiogenic signaling and considers the therapeutic potential of targeting these particular vascular factors.

* Corresponding author. E-mail, yihai.cao{at}ki.se

Citation: Y. Cao, Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands. Sci. Signal. 2, re1 (2009).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature.
E.-M. Hedlund, K. Hosaka, Z. Zhong, R. Cao, and Y. Cao (2009)
PNAS 106, 17505-17510
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882